| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ccd56851114d89a9a5ca18141ce4b6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bab34457c0c62aadf06ac0280240a61 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2019-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce23c851ce5e315bd7832fcc56814f71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee3a198635022a6ad9cfea680f5e5d24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93cd62663491c0fd108c29f385f944e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ed06b8a7a533c0670a88df3f2b3c2e4 |
| publicationDate |
2021-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2021396761-A1 |
| titleOfInvention |
Methods for screening and identifying agents that inhibit or modulate the nuclear egress complex of herpesviruses |
| abstract |
The present invention generally provides for a novel NEC-targeted strategy for the development of antiherpesviral drugs as well as for a novel antiviral strategy targeting the viral-cellular nuclear egress complex (NEC) for a small molecule-based therapy or prophylaxis to control infections with human cytomegalovirus or other pathogenic viruses of the group of the Herpesviridae. Methods for screening agents/compounds/small molecules modulating/inhibiting the nuclear egress complex of Herpesviridae are provided as well. Specifically novel drug targets of the viral nuclear egress complex of viruses of the Herpesviridae are provided. |
| priorityDate |
2018-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |